Pulsatiler Tinnitus nach Covid-19 Erkankung

Zusammenfassung

Nach einer Covid-19 Erkrankung vor einem Monat sind bei einem Patienten extreme Schmerzen im Kopf- und Nackenbereich sowie ein sehr störender, pulssynchroner (pulsatiler) Tinnitus (NRS 6–7/10) als Symptome geblieben. In der physiotherapeutischen Befundaufnahme wird klar, dass der Patient nicht physiotherapeutisch weiterbehandelt werden kann, sondern erst weiter von ärztlicher Seite abgeklärt werden muss. Nach dieser Abklärung und Freigabe zur Fortsetzung der Physiotherapie wird ein Behandlungsplan erarbeitet, der vor allem die Stressbewältigung des Patienten in den Mittelpunkt stellt. Gleichzeitig werden unterstützend manualtherapeutische Techniken an der Halswirbelsäule und der Kieferregion sowie Edukationsmaßnahmen eingesetzt. Durch die erfolgreiche Zusammenarbeit zwischen ärztlicher Abklärung, Physiotherapie und Psychotherapie sowie durch die gute Kommunikation mit dem Patienten kann dieser erfolgreich begleitet und eine deutliche Reduktion der Symptome erreicht werden.

Abstract

After being affected by Covid-19 a month before, a patient presented with ongoing symptoms of extreme headache, pain in the region of the neck and a very disturbing, pulse-synchronous (pulsatile) tinnitus (NRS 6–7/10). In the course of physiotherapeutic assessment, it transpires that the patient should not receive any physiotherapeutic treatment without previous medical clearance. After clearance is given to go ahead with physiotherapy, a treatment plan is developed, focusing primarily on the patient’s stress coping strategies. This is supported by educational measures as well as manual therapy techniques directed at the cervical spine and the mandibular region. Owing to a fruitful collaboration between medical clearance, physiotherapy and psychotherapy as well as good patient communication, the patient can be treated successfully and his symptoms are reduced significantly.

Schlüsselwörter

Pulsatiler Tinnitus - Red Flag - Differentialdiagnose - ärztliche Abklärung

Key words

pulsatile tinnitus - Red Flag - differential diagnosis - medical clearance

Publication History

Received: 06 July 2021

Accepted: 29 July 2021

Article published online:
18 May 2022

• Literatur

• 1 Hofmann E, Behr R, Neumann-Haefelin T. et al. Pulsatile tinnitus: imaging and differential diagnosis. Dtsch Arztebl Int 2013; 110: 451-458 DOI: 10.3238/arztebl.2013.0451.
• 2 Sismanis A. Pulsatile Tinnitus. A 15-year experience. Am J Otol 1998; 19: 472-477
• 3 Waldvogel D, Mattle HP, Sturzenegger M. et al. Pulsatile tinnitus—a review of 84 patients. J Neurol 1998; 245: 137-142 DOI: 10.1007/s004150050193.
• 4 Beukes E, Ulep AJ, Eubank T. et al. The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review. J Clin Med 2021; 10: 2763 DOI: 10.3390/jcm10132763.
• 5 Lüdtke K, Grauel L, Laube D. Screening in der Physiotherapie: Das Flaggen-System – Warnsignale erkennen. Stuttgart: Thieme Verlag; 2015
• 6 Alshawi Y, Ismail A, Almegil N. et al. The Effect of Valsalva and Toynbee Maneuvers on Tympanometry Parameters in Normal and Retracted Tympanic Membrane. Glob J Oto 2018; 14: 555896 DOI: 10.19080/GJO.2018.14.555896.
• 7 Pstras L, Thomaseth K, Waniewski J. et al. The Valsalva manoeuvre: physiology and clinical examples. Acta Physiol (Oxf) 2016; 217: 103-119 DOI: 10.1111/apha.12639.
• 8 Beukes EW, Onozuka J, Brazell TP. et al. Coping with tinnitus during the COVID-19 pandemic. Am J Audiol 2021; 30: 385-393 DOI: 10.1044/2021_AJA-20-00188.
• 9 Cabrera Martimbianco AL, Pacheco RL, Bagattini ÂM. et al. Frequency, signs and symptoms, and criteria adopted for long COVID: a systematic review. Int J Clin Pract 2021; 75: e14357 DOI: 10.1111/ijcp.14357.
• 10 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016; 18: 891-975 DOI: 10.1002/ejhf.592.
• 11 Clark CE, Taylor RS, Shore AC. et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet 2021; 379: 905-914 DOI: 10.1016/S0140-6736(11)61710-8.
• 12 Dunn L. T. (2002). Raised intracranial pressure. J Neurol Neurosurg Psychiatry 2002; 73 (Suppl. 01) i23-i27 DOI: 10.1136/jnnp.73.suppl_1.i23.
• 13 de Robles P, Fiest KM, Frolkis AD. et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol 2015; 17: 776-783 DOI: 10.1093/neuonc/nou283.
• 14 Gianotti SM, Marshall SW, Hume PA. et al. Incidence of anterior cruciate ligament injury and other knee ligament injuries: a national population-based study. J Sci Med Sport 2009; 12: 622-627 DOI: 10.1016/j.jsams.2008.07.005.
• 15 Taylor A, Mourad F, Kerry R. et al. A guide to cranial nerve testing for musculoskeletal clinicians. J Man Manip Ther 2021; 29: 376-389 DOI: 10.1080/10669817.2021.1937813.
• 16 Nilges P, Essau C. Die Depressions-Angst-Stress-Skalen: Der DASS--ein Screeningverfahren nicht nur für Schmerzpatienten [Depression, anxiety and stress scales: DASS--A screening procedure not only for pain patients]. Schmerz 2015; 29: 649-657 DOI: 10.1007/s00482-015-0019-z.
• 17 Sullivan MJ, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and Validation. Psychological Assessment 1996; 7: 524-532 DOI: 10.1037/1040-3590.7.4.524.
• 18 Osman A, Barrios FX, Gutierrez PM. et al. The Pain Catastrophizing Scale: further psychometric evaluation with adult samples. J Behav Med 2000; 23: 351-365 DOI: 10.1023/a:1005548801037.
• 19 Darnall BD, Sturgeon JA, Cook KF. et al. Development and validation of a daily pain catastrophizing scale. J Pain 2017; 18: 1139-1149 DOI: 10.1016/j.jpain.2017.05.003.
• 20 Vernon H. The Neck Disability Index: state-of-the-art, 1991–2008. J Manipulative Physiol Ther 2008; 491-502 DOI: 10.1016/j.jmpt.2008.08.006.
• 21 Gifford L. Pain, the tissues and the nervous system: a conceptual model. Physiotherapy 1998; 84: 27-36 DOI: 10.1016/S0031-9406(05)65900-7.
• 22 von Piekartz H, Maloul R, Hoffmann M. et al. Diagnostic accuracy and validity of three manual examination tests to identify alar ligament lesions: results of a blinded case-control study. J Man Manip Ther 2019; 27: 83-91 DOI: 10.1080/10669817.2018.1539434.
• 23 Jull GA, O’Leary SP, Falla DL. Clinical assessment of the deep cervical flexor muscles: the craniocervical flexion test. J Manipulative Physiol Ther 2008; 31: 525-533 DOI: 10.1016/j.jmpt.2008.08.003.